Literature DB >> 18278499

Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent.

Donato Rigante1, Domenica Battaglia, Ilaria Contaldo, Ilaria La Torraca, Laura Avallone, Stefania Gaspari, Giulia Bersani, Achille Stabile.   

Abstract

We report a 7-year-old boy who unexpectedly developed a multi-drug resistant epilepsy with negative neuroimaging results, followed by the insidious appearance of linear localized scleroderma involving the right leg. When the boy was 16 and severely affected by epileptic encephalopathy, we have evaluated this case for the first time: his localized scleroderma had reached the right buttock and positive anti-nuclear antibody was the only positive laboratory test. Methotrexate administered for 12 months was ineffective in improving both the organization of his electroencephalographic pattern and seizure control, though seemed to stabilize the progression of linear scleroderma. This report suggests that neurological abnormality and extracranial scleroderma might represent two own distinct processes in a same patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278499     DOI: 10.1007/s00296-008-0541-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

1.  Scleroderma "en coup de sabre": pathological evidence of intracerebral inflammation.

Authors:  J Stone; A J Franks; J A Guthrie; M H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Localized scleroderma associated with progressing ischemic stroke.

Authors:  N Kanzato; T Matsuzaki; Y Komine; M Saito; A Saito; T Yoshio; M Suehara
Journal:  J Neurol Sci       Date:  1999-02-01       Impact factor: 3.181

3.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

4.  Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic inflammatory process.

Authors:  G Pupillo; F Andermann; F Dubeau
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

5.  Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome.

Authors:  Justyna Paprocka; Ewa Jamroz; Dariusz Adamek; Elzbieta Marszal; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2005-10-25       Impact factor: 1.475

6.  The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.

Authors:  Francesco Zulian; Patricia Woo; Balu H Athreya; Ronald M Laxer; Thomas A Medsger; Thomas J A Lehman; Marco Matucci Cerinic; Giorgia Martini; Angelo Ravelli; Ricardo Russo; Ruben Cuttica; Sheila Knupp Feitosa de Oliveira; Christopher P Denton; Franco Cozzi; Ivan Foeldvari; Nicolino Ruperto
Journal:  Arthritis Rheum       Date:  2007-03-15

7.  Neuroimaging findings in scleroderma en coup de sabre.

Authors:  S Appenzeller; M A Montenegro; S San Juan Dertkigil; P D Sampaio-Barros; J F Marques-Neto; A M Samara; F Andermann; F Cendes
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

Review 8.  Localized scleroderma progressing to systemic disease. Case report and review of the literature.

Authors:  N Birdi; R M Laxer; P Thorner; M J Fritzler; E D Silverman
Journal:  Arthritis Rheum       Date:  1993-03

9.  Clinical and serologic expression of localized scleroderma. Case report and review of the literature.

Authors:  W W Piette; J K Dorsey; E Foucar
Journal:  J Am Acad Dermatol       Date:  1985-08       Impact factor: 11.527

10.  Treatment of pediatric localized scleroderma with methotrexate.

Authors:  Pamela G Fitch; Patricia Rettig; Jon M Burnham; Terri H Finkel; Albert C Yan; Evren Akin; Randy Q Cron
Journal:  J Rheumatol       Date:  2006-03       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.